Psomagen Inc (950200)

Currency in KRW
3,270
-40(-1.21%)
Closed·
Advertisement
950200 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3,2103,350
52 wk Range
2,3804,690
Key Statistics
Bid/Ask
3,255.00 / 3,270.00
Prev. Close
3,310
Open
3,280
Day's Range
3,210-3,350
52 wk Range
2,380-4,690
Volume
137.32K
Average Volume (3m)
350.66K
1-Year Change
-17.3198%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
950200 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Biotechnology industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Earnings

Latest Release
15/05/2026
EPS / Forecast
-15.00 / --
Revenue / Forecast
12.83B / --
EPS Revisions
Last 90 days

Compare 950200 to Peers and Sector

Metrics to compare
950200
Peers
Sector
Relationship
P/E Ratio
−40.0x−1.4x−0.4x
PEG Ratio
−0.560.000.00
Price/Book
2.2x1.2x2.6x
Price / LTM Sales
1.0x6.2x3.0x
Upside (Analyst Target)
-240.1%49.0%
Fair Value Upside
Unlock12.3%6.5%Unlock

Psomagen, Inc. engages in the provision omics solutions and contract laboratory services. The company’s research services includes genomics, a study of gene sequence and expression; epigenomics, a study of epigenetic changes, such as chromatin assembly, histone modification, and DNA-protein interaction in a cell; single-cell analysis, research in suspensions, biological fluids, tissues, or cell populations; metagenomics, a study of genetic material from microorganisms in heterogeneous samples; transcriptomics, a study of RNA and its expression through sequencing, used to analyze the impact of gene expression on the biology of an organism; and proteomics, a study of all the expressed proteins in an organism (proteome). It also offers Bioinformatics, a software tool and pipeline that helps scientists in analyzing data; and provides clinical genetic testing, whole-genome, whole-exome, and sanger sequencing services. The company was formerly known as Macrogen Corp. and changed its name to Psomagen, Inc. in April 2019. Psomagen, Inc. was incorporated in 2004 and is headquartered in Wilmington, Delaware. Psomagen, Inc. is a subsidiary of Macrogen, Inc.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
20.94M100.00%72.03B
Public Companies & Retail Investors
0.000.00%0.00
Total
20.94M100.00%72.03B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Macrogen, Inc.108.86%20,940,29572,034,615

FAQ

What Is the Psomagen (KOSDAQ: 950200) Share Price Today?

The Psomagen stock price today is 3,270 KRW.

What Stock Exchange Does Psomagen (950200) Trade On?

Psomagen is listed and trades on the KOSDAQ.

What Is the Ticker (Stock Symbol) for Psomagen?

The stock symbol (also called a 'ticker') for Psomagen is "950200."

What Is the Current Psomagen Market Capitalisation?

As of today, Psomagen (KOSDAQ: 950200) market cap is 63.67B KRW.

What Is Psomagen's (950200) Earnings Per Share (TTM)?

The Psomagen EPS is currently -79 (Trailing Twelve Months).

Is 950200 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Psomagen moving averages and other technical indicators, the daily buy/sell signal for 950200 stock is Sell.

How Many Times Has Psomagen Stock Split?

Psomagen has split 0 times. (See the 950200 stock split history page for full effective split date and price information.)

How Many Employees Does Psomagen Have?

Psomagen has 85 employees, based on their latest Companies House report.

What is the current trading status of Psomagen (KOSDAQ: 950200)?

As of 08/09/2026, Psomagen (950200) is trading at a share price of 3,270 KRW, with a previous close of 3,310 KRW. The stock has fluctuated within a day range of 3,210 KRW to 3,350 KRW, while its 52-week range spans from 2,380 KRW to 4,690 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.